How to buy IMV stock (IMV)

IMV is a biotechnology business based in the US. IMV shares (IMV) are listed on the NASDAQ and all prices are listed in US Dollars. IMV employs 63 staff and has a trailing 12-month revenue of around $329,000.

Our top picks for where to buy IMV stock

Buy IMV stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

IMV stock price (NASDAQ: IMV)

Use our graph to track the performance of IMV stocks over time.

IMV shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$0.00 - $0.00
50-day moving average more info button	$0.55
200-day moving average more info button	$2.73
Wall St. target price	$38.33
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-4.55

Is it a good time to buy IMV stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IMV financials

Revenue TTM	$329,000
Gross profit TTM	$-23,281,000
Return on assets TTM	-61.78%
Return on equity TTM	-508.58%
Profit margin	0%
Book value	$-0.69
Market Capitalization more info button	$9.8 million

TTM: trailing 12 months

IMV share dividends

We're not expecting IMV to pay a dividend over the next 12 months.

Have IMV's shares ever split?

IMV's shares were split on a 1:10 basis on 12 December 2022 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your IMV shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for IMV shares which in turn could have impacted IMV's share price.

IMV share price volatility

Over the last 12 months, IMV's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IMV's is 1.5224. This would suggest that IMV's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

IMV overview

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc.

Frequently asked questions

null
What percentage of IMV is owned by insiders or institutions?
Currently 0.412% of IMV shares are held by insiders and 20.37% by institutions. How many people work for IMV?
Latest data suggests 63 work at IMV. When does the fiscal year end for IMV?
IMV's fiscal year ends in December. Where is IMV based?
IMV's address is: 130 Eileen Stubbs Avenue, Dartmouth, NS, Canada, B3B 2C4 What is IMV's ISIN number?
IMV's international securities identification number is: CA44974L1031 What is IMV's CUSIP number?
IMV's Committee on Uniform Securities Identification Procedures number is: 44974L103